Characterization of haemorrhagic pulmonary capillaritis: Another manifestation of Pristane-induced lupus

Rheumatology

Volumn 46, Issue 9, 2007, Pages 1405-1410

  Chowdhary, V R ^a   Grande, J P ^b   Luthra, H S ^a   David, Chella S ^b  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Pristane induced lupus; Pulmonary vasculitis

Indexed keywords

ANTINUCLEAR ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHATE BUFFERED SALINE; PRISTANE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARITIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRON MICROSCOPY; ENDOTHELIUM INJURY; EOSINOPHIL; HEMORRHAGIC PULMONARY CAPILLARITIS; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; IMMUNOPATHOGENESIS; LIVER GRANULOMA; LUNG INFILTRATE; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; GRANULOMA, FOREIGN-BODY; HEMORRHAGE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; INTERLEUKIN-6; LUNG; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; TERPENES; VASCULITIS;

EID: 34548319654     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem117     Document Type: Article

References (37)

1. Satoh M, Reeves WH. Induction of lupus-assodated autoantibodies in BALB/ c mice by intraperitoneal injection of pristane. J Exp Med 1994;180:2341-6.
2. Satoh M, Kumar A, Kanwar YS, Reeves WH. Anti-nucleer antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci USA 1995;92:10934-8.
3. Satoh M, Richards HB, Shaheen VM et al, Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol 2000;121:399-405.
4. Richards HB, Satoh M, Jennette JC, Okano T, Kanwar YS, Reaves WH. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice. Clin Exp Immunol 1999;115:547-53.
5. Richards HB, Satoh M, Shaw M, Libert C, Poli V, Reeves WH. Interleukin 6 dependence of anti-DNA antibody production; evidence for two pathways of autoantibody formation in pristane-Induced lupus. J Exp Med 1998;188:985-90.
6. Richards HB, Satoh M, Jennette JC, Croker BP, Yoshida H, Reeves WH. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int 2001;60;2173-80.
7. Satoh M, Hamilton KJ, Ajmani AK et al. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol 1996;157:3200-6.
8. Yoshida H, Satoh M, Behney KM et al. Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice. Arthritis Rheum 2002;46:2235-44.
9. Calvani N, Satoh M, Croker BP, Reeves WH, Richards HB. Nephritogenic autoantibodies but absence of nephritis in 11-12p35-deficient mice with pristane-induced lupus. Kidney Int 2003;64:897-905.
10. Clynes R, Calvani N, Croker BP, Richards HB. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors. Clin Exp Immunol 2005;141:230-7.
11. Satoh M, Weintraub JP, Yoshida H et al. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus. J Immunol 2000;165;1036-43.
12. Chapoval SP, Nabozny GH, Marietta EV et al. Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. J Clin Invest 1999;103:1707-17.
13. Paisansinsup T, Deshmukh US, Chowdhary VR, Luthra HS, Fu SM, David CS. HLA class II influences the immune response and antibody diversification to Ro60/Sjogren's syndrome-A: Heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J Immunol 2002;168:5876-84.
14. McKenzie WN Jr, Sunderrajan EV, Kavanaugh JL, Braun S, Ansbacher L, Walker SE. Sex hormones modulate the response of pulmonary perivascular inflammation to cyclophosphamide therapy in MRL/MpJ-Ipr/Ipr mice. Am J Pathol 1988;131:530-8.
15. Paisansinsup T, Vallejo AN, Luthra H, David CS. HLA-DR modulates autoantibody repertoire, but not mortality, in a humanized mouse model of systemic lupus erythematosus. J Immunol 2001;167:4083-90.
16. McDowell EM, Trump BF. Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med 1976;100:405-14.
17. Spurr AR. A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res 1969;26:31-43.
18. Janz S, Shacter E. Disposition of the plasmacytomagenic alkane pristane (2,6,10, 14-tetramethylpentadecane) in mice. Cancer Biochem Biophys 1995;15:25-34.
19. Horii Y, Muraguchi A, Iwano M et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 1989;143:3949-55.
20. Patten C, Bush K, Rioja I et al. Characterization of pristane-induced arthritis, a murine model of chronic disease: Response to antirheumatic agents, expression of joint cytoldnes, and immunopathology. Arthritis Rheum 2004;50:3334-45.
21. Barbarin V, Xing Z, Delos M, Lison D, Huaux F. Pulmonary overexpresslon of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am J Physiol Lung Cell Mol Physiol 2005;288:L841-8.
22. Martinez JA, King TE Jr, Brown K et al. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. Am J Physiol 1997;273:L676-83.
23. van der Sluijs KF, van Elden LJ, Nijhuis M et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 2004;172:7603-9.
24. Wogensen L, Huang X, Sarvetnick N. Leukocyts extravesation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 1993;178:175-85.
25. Llorente L, Zou W, Levy Y et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995;181:839-44.
26. Beebe AM, Cua DJ, de Waal Maletyt R. The role of interleukin-10 in autoimmune disease: Systemic lupus erythematosus (SLE) and imultiple sclerosis (MS). Cytokine Growth Factor Rev 2002;3:403-12.
27. Cross JT, Benton HP. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus. Inflamm Res 1999;48:255-61.
28. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Marion S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994;179:305-10.
29. Mongan AE, Ramdahin S, Warrington RJ. Interleukin-10 response abnormalities in systemic lupus erythematosus. Scand J Immunol 1997;46:406-12.
30. Llorente L, Richaud-Patin Y, Garcia-Padilla C et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 2000;43:1790-800.
31. Castaneda S, Herrero-Beaumont G, Valenzuela, A et al. Massive pulmonary hemorrhage: Fatal complication of systemic lupus erythematosus. J Rheumatol 1986;12:186-7.
32. Mintz G, Galindo LF, Fernandez-Diez J, Jimenez FJ, Robles-Saavedra E, Enriquez-Casillas RD. Acute massive pulmonary hemorrhage in systemic lupus erythematosus. J Rheumatol 1978;5:39-50.
33. Myers JL, Katzenstein AA. Microangitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986;85:552-6.
34. Castanede S, Herraro-Beaumont G, Aguado JM et al. Pulmonary hemorrhage in lupus erythematosus without evidence of an immunologic cause. Arch intern Med 1985;145:2128-9.
35. Desnoyers MR, Bernstein S, Cooper AG, Kopelman Rt. Pulmonary hemorrhage in lupus erythematosus without evidence of an immunologic cause. Arch Intern Med 1984;144:1398-400.
36. Brentjens JR, O'Connell DW, Pawlowski IB, Hsu KC, Andres GA. Experimental immune complex disesse of the lung. The pathogenesis of a laboratory model resembling certain human interstitial lung diseases. J Exp Med 1974;140:105-25.
37. Leatherman JW, Davies SF, Hoidal JR. Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine (Baltimore) 1984;63:343-61.